Applied Dna Sciences Inc (NASDAQ:APDN) shares, rose in value, with the stock price up by 1.37% to the previous day’s close as strong demand from buyers drove the stock to $0.81.
Actively observing the price movement in the last trading, the stock closed the session at $0.80, falling within a range of $0.77 and $0.83. The value of beta (5-year monthly) was 0.843. Referring to stock’s 52-week performance, its high was $376.30, and the low was $0.78. On the whole, APDN has fluctuated by -59.45% over the past month.
With the market capitalization of Applied Dna Sciences Inc currently standing at about $5.27 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-12.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 5.28M, with a low estimate of 1.19M and a high estimate of 1.19M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.19M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that APDN’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of APDN currently trading nearly -44.04% and -81.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 19.36, while the 7-day volatility ratio is showing 13.66% which for the 30-day chart, stands at 17.51%. Furthermore, Applied Dna Sciences Inc (APDN)’s beta value is 0.59, and its average true range (ATR) is 0.35.
A comparison of Applied Dna Sciences Inc (APDN) with its peers suggests the former has fared considerably weaker in the market. APDN showed an intraday change of 1.37% in last session, and over the past year, it shrunk by -99.76%%.
Data on historical trading for Applied Dna Sciences Inc (NASDAQ:APDN) indicates that the trading volumes over the past 10 days have averaged 1.37 and over the past 3 months, they’ve averaged 1.16 million. According to company’s latest data on outstanding shares, there are 6.50 million shares outstanding.
Nearly 6.82% of Applied Dna Sciences Inc’s shares belong to company insiders and institutional investors own 6.72% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.74 million shares as on 2025-03-31, resulting in a short ratio of 0.34. According to the data, the short interest in Applied Dna Sciences Inc (APDN) stood at 11599.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 60080.0. The stock has fallen by -92.05% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the APDN stock heading into the next quarter.
